Tikvah signs agreement with Therapade to develop and commercialize compounds to treat anxiety-related disorders.

BIOTECH Patent News, February, 2007

Tikvah Therapeutics, Inc. (Atlanta, GA) signed a licensing agreement with Therapade Technologies LLC, a drug development company founded by researchers at the Emory University School of Medicine (Atlanta, GA) and the College of William and Mary (Wlliamsburg, VA), for worldwide rights to develop and commercialize D-cycloserine and related compounds for the treatment of numerous anxiety-related disorders, including post-traumatic stress disorder, panic disorder, social phobia, obsessive compulsive disorder (OCD), as well as other afflictions exacerbated by anxiety. Tikvah Therapeutics will also explore additional indications for D-cycloserine through its own research and development efforts and the support of further investigator initiated clinical trials.

...

Read the rest of this article with a Free Trial at HighBeam Research.

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works.